Anti-Human ASL Polyclonal Antibody

Catalog No.

PHC09101

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human ASL (Met1-Ala464).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

ASAL, Arginosuccinase, Argininosuccinate lyase, ASL

Purification

Purified by antigen affinity column.

Accession

P04424

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025., PMID:40469214

Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study., PMID:40442445

Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications., PMID:40427162

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy., PMID:40402266

Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity., PMID:40399681

Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study., PMID:40376617

Human Endogenous Retroviruses as Novel Therapeutic Targets in Neurodegenerative Disorders., PMID:40333317

Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study., PMID:40325793

Predictors of response to burosumab in adults with X-linked hypophosphatemia: real-world data from an Italian cohort., PMID:40323576

Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer's disease: the challenges ahead., PMID:40314575

The Prevalence, Risk Factors, and Outcomes of Hepatitis E Virus Infection in Solid Organ Transplant Recipients in a Highly Endemic Area of Italy., PMID:40284945

Prognostic relevance of bone marrow immune cell fractions in newly diagnosed B-cell non-Hodgkin lymphoma patients., PMID:40232295

Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry")., PMID:40180601

Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study., PMID:40147217

INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia., PMID:40120068

Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients., PMID:40103518

Cryfibrinogen-Associated Glomerulonephritis and Monoclonal Gammopathy of Renal Significance-Case Report and Literature Review., PMID:40095671

Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial., PMID:40088800

Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab., PMID:40087324

Is it time to consider west Nile and Usutu viruses endemic in central Italy?, PMID:40081763

Decoding the Puzzle of Male Infertility: The Role of Infection, Inflammation, and Autoimmunity., PMID:40075794

Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis)., PMID:40004618

Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis., PMID:39943891

Mast Cells at the Crossroads of Hypersensitivity Reactions and Neurogenic Inflammation., PMID:39940696

Ixekizumab as a successful treatment in pediatric generalized pustular psoriasis., PMID:39934839

Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study., PMID:39898517

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial., PMID:39874903

Analyzing free fatty acids in seminal plasma from asthenozoospermia patients undergoing antioxidant therapy., PMID:39873419

Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review., PMID:39869010

Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study., PMID:39862304

Celiac Disease: A Transitional Point of View., PMID:39861364

Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort., PMID:39856001

Symptomatic Improvement in Adults and Adolescents With Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure Than Histologic Response., PMID:39853721

Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot study., PMID:39835128

Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae., PMID:39832911

The cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular density., PMID:39831960

Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders., PMID:39823554

Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies., PMID:39808882

How We Treat ANCA-Associated Vasculitis: A Focus on the Maintenance Therapy., PMID:39797292

Biomarkers of Extracellular Matrix Fragments in Patients with Psoriasis., PMID:39796116

Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients., PMID:39778329

Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter Study., PMID:39768862

Diagnostic utility of magnetic resonance imaging in autoimmune encephalitis: prognostic implications., PMID:39764590

IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes., PMID:39760686

In vivo tracking of ex-vivo-generated 89Zr-oxine-labeled plasma cells by PET in a non-human primate model., PMID:39741408

Simultaneous treatment with benralizumab and ustekinumab in a patient with severe asthma and ulcerative colitis., PMID:39718916

Attention deficit hyperactivity disorder combined subtype and Anti-Yo antibodies., PMID:39704671

Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy: Seasonal patterns of myositis autoantibodies., PMID:39681209

Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis., PMID:39657020

Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis., PMID:39666131

Document Download

Anti-Human ASL Polyclonal Antibody.pdf